Cataract Clinical Trial
Official title:
CSP #338 - Comparison of Anterior and Posterior Chamber Lens Implants After Vitreous Loss in Attempted Extracapsular Cataract Extraction
Objective: The standard definition of failure in cataract surgery is best corrected visual
acuity of less than 20/40 at one year. The specific aim of this cooperative study was to
compare the failure rate for those patients with vitreous loss in whom an PC IOL is placed
to the failure rate for those in whom an AC IOL is placed after vitreous loss.
Design: A total of 437 patients in 15 centers were randomized to AC or PC IOL over a
45-month period and were followed for a minimum of one year. The null hypothesis is that the
rate of failure is the same in the two groups.
All patients who were about to undergo cataract surgery in the participating centers and who
did not meet an exclusion criterion were eligible for the study. At the time of surgery, if
there was vitreous loss, and if in the opinion of the surgeon there was sufficient capsular
support for a posterior chamber lens to be placed, then the patient was randomized into one
of either the anterior or posterior chamber lens groups. The patients were then followed for
complications (e.g., retinal detachment, cystoid macular edema, uveitis, glaucoma, hyphema)
and for the primary end point of visual acuity of 20/40 or better at one postoperative year.
An "Index Group" of about 500 patients without vitreous loss also were followed according to
study protocol. These patients were compared to those in the PC and AC IOL groups with
respect to outcome and baseline characteristics in order to assess the effect of vitreous
loss on complication rates.
All patients were followed at annual intervals until the termination of the study. This
allowed the study to obtain long-term information with regard to visual acuity and
complication rates.
Primary Hypothesis: There is no difference in failure rate between patients receiving
anterior chamber or posterior chamber intraocular lenses following vitreous loss in
extracapsular cataract extraction (ECCE).
Secondary Hypothesis: None
Intervention: 1) Anterior chamber intraocular lens, 2) Posterior chamber intraocular lens.
Primary Outcome: Failure defined as best corrected visual acuity less than 20/40 one year
following ECCE.
Study Abstract: Extracapsular cataract surgery with posterior chamber intraocular lens
implantation is one of the most common and most successful of surgical procedures. In the
United States alone approximately 1.4 million cataract extractions were performed in 1990.
Of these the overwhelming majority do well. However, the principal complication, vitreous
loss, occurs in about 5% of cases. It is often sight-limiting.
Placement of an intraocular lens in the presence of vitreous loss is controversial. The
standard approach following anterior vitrectomy usually involves placement of an anterior
chamber intraocular lens (AC IOL). However, it has been suggested that implantation of a
posterior chamber intraocular lens (PC IOL) in many of these patients is not only possible,
but preferable.
In this study, eligible patients were VA patients who had vitreous loss during attempted
ECCE. At each occurrence of vitreous loss, the patients were randomly assigned to have an AC
IOL or PC IOL. Patient recruitment was terminated early with 438 patients enrolled in 15
centers. Patients were followed to the completion of at least one-year follow-up.
An ?Index Group?of 500 patients without vitreous loss also was followed according to study
protocol. These patients will be compared to those in the PC and AC IOL groups with respect
to outcome and baseline characteristics in order to assess the effect of vitreous loss on
complication rates.
Results: More PC IOL patients (91%) achieved visual acuity of 20/40 or better at one year
than AC IOL patients (79%). A highly significant difference (p=0.003). There was no
significant difference between the two groups for patients' rating of vison or adverse
events. Over 84% of the PC IOL patients and over 77% of the AC IOL patients rated their
vision as good or better at one year as opposed to only 7% giving such ratings prior to
surgery. For at least one rating period during the first year, 13.2% of the combined study
patients had cystoid macular edema, 8.5% had posterior capsule opacification, 5.7% had
glaucoma, and 3.7% had retinal detachment.
Conclusion: In the presence of sufficient capsular support, a PC IOL should be implanted
after vitreous presentation during ECCE.
Collins JF, Krol WF, Gaster RN, Colling CL, Kirk GF, Smith TJ - A Comparison of Anterior
Chamber and Posterior Chamber IOL's after Vitreous Loss during Cataract Surgery. The VA
Cooperative Cataract Study. American Journal of Ophthalmology. 136:1-9, 2003
Collins JF, Krol WF, Kirk GF, Gaster, RN - The Effect of Vitreous Presentation During
Extracapsular Cataract Surgery on the Postoperative Visual Acuity at One Year. American
Journal of Ophthalmology. 138:536-542, 2004
Collins, JF, Gaster,RN, Krol,WF and the VA Cooperative Cataract Study Group. Outcomes in
Patients Having Vitreous Presentation During Cataract Surgery Who Lack Capsular Support for
a Nonsutured PC IOL. American Journal of Ophthalmology, Vol 141:71-78, 2006
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
| Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
| Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
| Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
| Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
| Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
| Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
| Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
| Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
| Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
| Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
| Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
| Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
| Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
| Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
| Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
| Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
| Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
| Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
| Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |